Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 140 articles:
HTML format
Text format



Single Articles


    July 2018
  1. ALAVIAN SM, Sharafi H
    Comment on 'Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study'.
    Eur J Gastroenterol Hepatol. 2018;30:807-808.
    PubMed     Text format    


  2. OZCELIK F, Sertoglu E
    Povital role of platelet count in platelet-lymphocyte count used in distinguishing patients with significant liver fibrosis and insulin resistance.
    Eur J Gastroenterol Hepatol. 2018;30:807.
    PubMed     Text format    


    June 2018
  3. SHANMUGAM RP, Balakrishnan S, Varadhan H, Shanmugam V, et al
    Prevalence of hepatitis B and hepatitis C infection from a population-based study in Southern India.
    Eur J Gastroenterol Hepatol. 2018 Jun 8. doi: 10.1097/MEG.0000000000001180.
    PubMed     Text format     Abstract available


    May 2018
  4. YOON CH, Jin YJ, Lee JW
    Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Eur J Gastroenterol Hepatol. 2018 May 29. doi: 10.1097/MEG.0000000000001174.
    PubMed     Text format     Abstract available


  5. ISAKOV V, Paduta D, Viani RM, Enejosa JV, et al
    Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV).
    Eur J Gastroenterol Hepatol. 2018 May 14. doi: 10.1097/MEG.0000000000001166.
    PubMed     Text format     Abstract available


  6. AGUILERA A, Trastoy R, Rodriguez-Calvino J, Manso T, et al
    Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.
    Eur J Gastroenterol Hepatol. 2018 May 8. doi: 10.1097/MEG.0000000000001163.
    PubMed     Text format     Abstract available


  7. CHEN B, Wang YH, Qian JQ, Wu DB, et al
    Human mesenchymal stem cells for hepatitis B virus-related acute-on-chronic liver failure: a systematic review with meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 May 3. doi: 10.1097/MEG.0000000000001156.
    PubMed     Text format     Abstract available


  8. TACHI Y, Hirai T, Kojima Y, Ishizu Y, et al
    Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.
    Eur J Gastroenterol Hepatol. 2018 May 2. doi: 10.1097/MEG.0000000000001159.
    PubMed     Text format     Abstract available


  9. HUANG R, Wang J, Xia J, Hao Y, et al
    Platelets-to-lymphocyte ratio as a predictor of liver fibrosis and insulin resistance in hepatitis C virus infection: more evidence is needed.
    Eur J Gastroenterol Hepatol. 2018;30:583.
    PubMed     Text format    


  10. HASSANY M, Elsharkawy A, Maged A, Mehrez M, et al
    Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact.
    Eur J Gastroenterol Hepatol. 2018 May 1. doi: 10.1097/MEG.0000000000001152.
    PubMed     Text format     Abstract available


  11. FOUAD R, Elbaz T, Abdel Alem S, Elsharkawy A, et al
    Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.
    Eur J Gastroenterol Hepatol. 2018 May 1. doi: 10.1097/MEG.0000000000001151.
    PubMed     Text format     Abstract available


    April 2018
  12. MENDES LC, Ferreira PA, Miotto N, Zanaga L, et al
    Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality.
    Eur J Gastroenterol Hepatol. 2018 Apr 30. doi: 10.1097/MEG.0000000000001145.
    PubMed     Text format     Abstract available


  13. SPAHR L, Goossens N, Furrer F, Dupuis M, et al
    A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis.
    Eur J Gastroenterol Hepatol. 2018 Apr 30. doi: 10.1097/MEG.0000000000001148.
    PubMed     Text format     Abstract available


  14. GOKCE O, Ozenirler S, Atak Yucel A, Oruklu N, et al
    Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2018 Apr 20. doi: 10.1097/MEG.0000000000001123.
    PubMed     Text format     Abstract available


  15. JIN CN, Chen JD, Sheng JF
    Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?
    Eur J Gastroenterol Hepatol. 2018 Apr 16. doi: 10.1097/MEG.0000000000001134.
    PubMed     Text format     Abstract available


  16. SPINICCI M, Emmi G, Dies L, Barilaro A, et al
    Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases.
    Eur J Gastroenterol Hepatol. 2018 Apr 11. doi: 10.1097/MEG.0000000000001132.
    PubMed     Text format     Abstract available


  17. SU YC, Lin PC, Yu HC, Wu CC, et al
    Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
    Eur J Gastroenterol Hepatol. 2018 Apr 4. doi: 10.1097/MEG.0000000000001130.
    PubMed     Text format     Abstract available


  18. EFE C, Ozaslan E, Purnak T
    Second-line immunosuppressants for autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2018;30:490-491.
    PubMed     Text format    


    February 2018
  19. KOBAYASHI N, Iijima H, Tada T, Kumada T, et al
    Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
    Eur J Gastroenterol Hepatol. 2018 Feb 28. doi: 10.1097/MEG.0000000000001106.
    PubMed     Text format     Abstract available


  20. PYRSOPOULOS N, Trilianos P, Lingiah VA, Fung P, et al
    The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data.
    Eur J Gastroenterol Hepatol. 2018 Feb 23. doi: 10.1097/MEG.0000000000001101.
    PubMed     Text format     Abstract available


  21. SAGNELLI E, Stroffolini T, Sagnelli C, Cacopardo B, et al
    Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.
    Eur J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1097/MEG.0000000000001099.
    PubMed     Text format     Abstract available


  22. ZHANG Y, Shi Y, Wu R, Wang X, et al
    Primary biliary cholangitis is more severe in previous hepatitis B virus infection patients.
    Eur J Gastroenterol Hepatol. 2018 Feb 16. doi: 10.1097/MEG.0000000000001100.
    PubMed     Text format     Abstract available


  23. HUANG R, Zhao XA, Wang J, Hao Y, et al
    Simple noninvasive tests for the detection of advanced liver fibrosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2018;30:241.
    PubMed     Text format    


    January 2018
  24. ADHOUTE X, Penaranda G, Raoul JL, Sellier F, et al
    Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study.
    Eur J Gastroenterol Hepatol. 2018 Jan 30. doi: 10.1097/MEG.0000000000001082.
    PubMed     Text format     Abstract available


  25. LULLAU A, Petroff D, Batz O, Kramer J, et al
    Linkage to care of HbsAg-positive and anti-HCV-positive patients after a systematic screening approach in the German primary care setting.
    Eur J Gastroenterol Hepatol. 2018 Jan 10. doi: 10.1097/MEG.0000000000001052.
    PubMed     Text format     Abstract available


  26. PANG Q, Zhou L, Qu K, Cui RX, et al
    Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study.
    Eur J Gastroenterol Hepatol. 2018;30:60-70.
    PubMed     Text format     Abstract available


    December 2017
  27. ROULOT D, Thibault V, Laforest C, Fontaine H, et al
    Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.
    Eur J Gastroenterol Hepatol. 2017 Dec 21. doi: 10.1097/MEG.0000000000001035.
    PubMed     Text format     Abstract available


  28. ALSEBAEY A, Elhelbawy M, Waked I
    Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease.
    Eur J Gastroenterol Hepatol. 2017 Dec 13. doi: 10.1097/MEG.0000000000001013.
    PubMed     Text format     Abstract available


  29. DE LEMOS-BONOTTO M, Valle-Tovo C, Costabeber AM, Mattos AA, et al
    A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment.
    Eur J Gastroenterol Hepatol. 2017 Dec 8. doi: 10.1097/MEG.0000000000001019.
    PubMed     Text format     Abstract available


  30. BASHIR MH, Fazili J, Madhoun MF, Kanagala R, et al
    Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis.
    Eur J Gastroenterol Hepatol. 2017 Dec 1. doi: 10.1097/MEG.0000000000001032.
    PubMed     Text format     Abstract available


    November 2017
  31. LIN Z, Liang J, Zhu J, Hu C, et al
    Diverse correlations between fibrosis-related factors and liver stiffness measurement by transient elastography in chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 Nov 29. doi: 10.1097/MEG.0000000000001023.
    PubMed     Text format     Abstract available


  32. MOSER S, Kozbial K, Laferl H, Schutz A, et al
    Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.
    Eur J Gastroenterol Hepatol. 2017 Nov 8. doi: 10.1097/MEG.0000000000001027.
    PubMed     Text format     Abstract available


  33. SAAD Y, Awad A, Alakel W, Doss W, et al
    Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients.
    Eur J Gastroenterol Hepatol. 2017 Nov 2. doi: 10.1097/MEG.0000000000001008.
    PubMed     Text format     Abstract available


  34. HUANG R, Wang J, Zhao XA, Xia J, et al
    The impact of cirrhosis on the efficacy and safety of entecavir for patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017;29:1314.
    PubMed     Text format    


    October 2017
  35. ABDELAZIZ AO, Nabil MM, Abdelmaksoud AH, Shousha HI, et al
    De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.
    Eur J Gastroenterol Hepatol. 2017 Oct 23. doi: 10.1097/MEG.0000000000001004.
    PubMed     Text format     Abstract available


  36. SIMONETTI G, Gitto S, Golfieri L, Gamal N, et al
    Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients.
    Eur J Gastroenterol Hepatol. 2017 Oct 23. doi: 10.1097/MEG.0000000000000999.
    PubMed     Text format     Abstract available


  37. WIJARNPREECHA K, Chesdachai S, Jaruvongvanich V, Ungprasert P, et al
    Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2017 Oct 18. doi: 10.1097/MEG.0000000000000991.
    PubMed     Text format     Abstract available


  38. KORDA D, Lenard ZM, Gerlei Z, Jakab Z, et al
    Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.
    Eur J Gastroenterol Hepatol. 2017 Oct 18. doi: 10.1097/MEG.0000000000001003.
    PubMed     Text format     Abstract available


  39. ABDEL-RAZIK A, Mousa N, Zakaria S, Elhelaly R, et al
    New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume.
    Eur J Gastroenterol Hepatol. 2017 Oct 13. doi: 10.1097/MEG.0000000000000982.
    PubMed     Text format     Abstract available


  40. FAN Y, Cao W, Di H, Liu C, et al
    Assessment of liver fibrosis with acoustic radiation force impulse in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2017;29:1190.
    PubMed     Text format    


    September 2017
  41. MOHAMED MS, Hanafy AS, Bassiony MAA, Hussein S, et al
    Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2017 Sep 25. doi: 10.1097/MEG.0000000000000963.
    PubMed     Text format     Abstract available


  42. TRIANTOS CK, Tsintoni A, Karaivazoglou K, Grigoropoulou X, et al
    Male hepatitis C patients' sexual functioning and its determinants.
    Eur J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1097/MEG.0000000000000971.
    PubMed     Text format     Abstract available


  43. WRIGHT N, Reimer J, Somaini L, Roncero C, et al
    Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model.
    Eur J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1097/MEG.0000000000000962.
    PubMed     Text format     Abstract available


  44. LANG S, Kutting F, Staub A, Schramowski J, et al
    Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 Sep 6. doi: 10.1097/MEG.0000000000000977.
    PubMed     Text format     Abstract available


  45. MILAZZO L, Magni C, Niero F, Schiavini M, et al
    Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience.
    Eur J Gastroenterol Hepatol. 2017 Sep 4. doi: 10.1097/MEG.0000000000000965.
    PubMed     Text format     Abstract available


  46. MOUSA N, Abdel-Razik A, Farag R, Shabana W, et al
    Do we need to screen for de-novo diabetes mellitus in chronic hepatitis C patients after a sustained virological response?
    Eur J Gastroenterol Hepatol. 2017;29:1004-1009.
    PubMed     Text format     Abstract available


  47. TRIANTOS C, Kalafateli M, Aggeletopoulou I, Mandellou M, et al
    Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis.
    Eur J Gastroenterol Hepatol. 2017;29:998-1003.
    PubMed     Text format     Abstract available


    August 2017
  48. DOLMAZASHVILI E, Abutidze A, Chkhartishvili N, Karchava M, et al
    Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA e
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000964.
    PubMed     Text format     Abstract available


  49. SIMS OT, Guo Y, Shoreibah MG, Venkata K, et al
    Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study in a large urban tertiary center.
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000961.
    PubMed     Text format     Abstract available


  50. MANGLA N, Mamun R, Weisberg IS
    Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy.
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000950.
    PubMed     Text format     Abstract available


  51. KARAIVAZOGLOU K, Tsermpini EE, Assimakopoulos K, Triantos C, et al
    Sexual functioning in patients with chronic hepatitis C: a systematic review.
    Eur J Gastroenterol Hepatol. 2017 Aug 22. doi: 10.1097/MEG.0000000000000949.
    PubMed     Text format     Abstract available


  52. MIOTTO N, Mendes LC, Zanaga LP, Goncales ESL, et al
    Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis: results of a real-life cohort.
    Eur J Gastroenterol Hepatol. 2017 Aug 10. doi: 10.1097/MEG.0000000000000944.
    PubMed     Text format     Abstract available


    July 2017
  53. POGORZELSKA J, Lapinska M, Kalinowska A, Lapinski TW, et al
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2017 Jul 11. doi: 10.1097/MEG.0000000000000928.
    PubMed     Text format     Abstract available


    June 2017
  54. FERNANDES SR, Marques da Costa P, Vitor S, Carvalho JR, et al
    Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
    Eur J Gastroenterol Hepatol. 2017 Jun 16. doi: 10.1097/MEG.0000000000000926.
    PubMed     Text format     Abstract available


  55. VEIGA ZST, Villela-Nogueira CA, Fernandes FF, Cavalcanti MG, et al
    Transient elastography evaluation of hepatic and spleen stiffness in patients with hepatosplenic schistosomiasis.
    Eur J Gastroenterol Hepatol. 2017;29:730-735.
    PubMed     Text format     Abstract available


    May 2017
  56. SERIGADO JM, Izzy M, Kalia H
    Novel therapies and potential therapeutic targets in the management of chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 May 19. doi: 10.1097/MEG.0000000000000911.
    PubMed     Text format     Abstract available


  57. STROFFOLINI T, Sagnelli E, Almasio PL, Andriulli A, et al
    Etiological factors of chronic hepatitis in Italy: a 2014 national survey.
    Eur J Gastroenterol Hepatol. 2017 May 19. doi: 10.1097/MEG.0000000000000907.
    PubMed     Text format     Abstract available


  58. WANG PC, Wei TY, Tseng TC, Lin HH, et al
    Cirrhosis has no impact on therapeutic responses of entecavir for chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 May 19. doi: 10.1097/MEG.0000000000000897.
    PubMed     Text format     Abstract available


  59. JABLONKA A, Solbach P, Wobse M, Manns MP, et al
    Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.
    Eur J Gastroenterol Hepatol. 2017 May 10. doi: 10.1097/MEG.0000000000000889.
    PubMed     Text format     Abstract available


  60. HUANG R, Xia J, Liu Y, Zhang Z, et al
    Acoustic radiation force impulse in the diagnosis of liver fibrosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000902.
    PubMed     Text format    


  61. WAHID B, Saleem K, Ali A, Rafique S, et al
    Rising relapse rate in hepatitis C virus type 3a-infected patients against sofosbuvir and ribavirin combination therapy: a Pakistani experience.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000895.
    PubMed     Text format    


  62. KOHLA MAS, Abbasy M, Abozeid M, El-Abd O, et al
    Assessment of liver fibrosis with acoustic radiation force impulse imaging versus liver histology in patients with chronic hepatitis C: a pilot study.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000903.
    PubMed     Text format     Abstract available


  63. CHEN D, Luo S, Ben Q, Lu L, et al
    Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China.
    Eur J Gastroenterol Hepatol. 2017;29:509-515.
    PubMed     Text format     Abstract available


  64. IINO C, Shimoyama T, Igarashi T, Aihara T, et al
    Usefulness of the Glasgow-Blatchford score to predict 1-week mortality in patients with esophageal variceal bleeding.
    Eur J Gastroenterol Hepatol. 2017;29:547-551.
    PubMed     Text format     Abstract available


  65. SOURIANARAYANANE A, Talluri J, Humar A, McCullough AJ, et al
    Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis.
    Eur J Gastroenterol Hepatol. 2017;29:516-523.
    PubMed     Text format     Abstract available


    April 2017
  66. CORDERO-RUIZ P, Carmona-Soria I, Rodriguez-Tellez M, Caunedo-Alvarez A, et al
    Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.
    Eur J Gastroenterol Hepatol. 2017 Apr 25. doi: 10.1097/MEG.0000000000000886.
    PubMed     Text format     Abstract available


  67. MARCELLIN F, Protopopescu C, Esterle L, Wittkop L, et al
    Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
    Eur J Gastroenterol Hepatol. 2017 Apr 17. doi: 10.1097/MEG.0000000000000883.
    PubMed     Text format     Abstract available


  68. TABERNILLA A, Grandal M, Pernas B, Castro-Iglesias A, et al
    Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration.
    Eur J Gastroenterol Hepatol. 2017 Apr 13. doi: 10.1097/MEG.0000000000000882.
    PubMed     Text format     Abstract available


    March 2017
  69. SHERIGAR JM, Gayam V, Khan A, Mukhtar O, et al
    Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2017 Mar 24. doi: 10.1097/MEG.0000000000000871.
    PubMed     Text format     Abstract available


  70. JI F, Tian C, Li Z, Deng H, et al
    Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older.
    Eur J Gastroenterol Hepatol. 2017 Mar 21. doi: 10.1097/MEG.0000000000000873.
    PubMed     Text format    


  71. MURATORI P, Efe C, Muratori L, Ozaslan E, et al
    Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study.
    Eur J Gastroenterol Hepatol. 2017 Mar 21. doi: 10.1097/MEG.0000000000000870.
    PubMed     Text format     Abstract available


  72. TANWAR S, Trembling PM, Hogan BJ, Srivastava A, et al
    Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.
    Eur J Gastroenterol Hepatol. 2017;29:289-296.
    PubMed     Text format     Abstract available


    February 2017
  73. ZHENG YX, Zhou PC, Zhou RR, Fan XG, et al
    The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2017 Feb 24. doi: 10.1097/MEG.0000000000000867.
    PubMed     Text format     Abstract available


  74. TAVARES RC, Feldner AC, Pinho JR, Uehara SN, et al
    Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2017 Feb 23. doi: 10.1097/MEG.0000000000000866.
    PubMed     Text format     Abstract available


  75. RONCERO C, Littlewood R, Vega P, Martinez-Raga J, et al
    Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment.
    Eur J Gastroenterol Hepatol. 2017 Feb 22. doi: 10.1097/MEG.0000000000000855.
    PubMed     Text format     Abstract available


  76. SU F, Beste LA, Green PK, Berry K, et al
    Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000858.
    PubMed     Text format     Abstract available


  77. GAO F, Sun L, Ye X, Liu Y, et al
    Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000854.
    PubMed     Text format     Abstract available


  78. NORTH CS, Pollio DE, Sims OT, Jain MK, et al
    An effectiveness study of group psychoeducation for hepatitis C patients in community clinics.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000860.
    PubMed     Text format     Abstract available


  79. SILVA MJ, Pereira C, Loureiro R, Balsa C, et al
    Hepatitis C in a Mobile Low-Threshold Methadone Program.
    Eur J Gastroenterol Hepatol. 2017 Feb 1. doi: 10.1097/MEG.0000000000000843.
    PubMed     Text format     Abstract available


  80. OZTURKER C, Karagoz E, Sivrioglu AK, Kara K, et al
    Clinical usefulness and performance of acoustic radiation force impulse in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 Feb 1. doi: 10.1097/MEG.0000000000000842.
    PubMed     Text format     Abstract available


  81. LIONCO LC, de Mattos AA, Horbe AF, Costabeber AM, et al
    Treatment of hepatocellular carcinoma using transarterial chemoembolization: a real-life, single-centre study from Southern Brazil.
    Eur J Gastroenterol Hepatol. 2017;29:225-230.
    PubMed     Text format     Abstract available


    January 2017
  82. CHEN D, Luo S, Ben Q, Lu L, et al
    Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China.
    Eur J Gastroenterol Hepatol. 2017 Jan 21. doi: 10.1097/MEG.0000000000000838.
    PubMed     Text format     Abstract available


  83. THONNES S, Friedel H, Frohlich H
    The number of patients with chronic hepatitis C in times of new therapy options: a retrospective observational study on German health insurance funds data.
    Eur J Gastroenterol Hepatol. 2017 Jan 12. doi: 10.1097/MEG.0000000000000819.
    PubMed     Text format     Abstract available


  84. ZHU S, Waili Y, Qi X, Chen Y, et al
    Lymphocyte-monocyte ratio at admission predicts possible outcomes in patients with acute-on-chronic liver failure.
    Eur J Gastroenterol Hepatol. 2017;29:31-35.
    PubMed     Text format     Abstract available


  85. PAPADOPOULOS N, Deutsch M, Manolakopoulos S, Bitsi C, et al
    Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Eur J Gastroenterol Hepatol. 2017;29:56-60.
    PubMed     Text format     Abstract available


    December 2016
  86. HUANG SS, Xie DM, Cai YJ, Wu JM, et al
    C-reactive protein-to-albumin ratio is a predictor of hepatitis B virus related decompensated cirrhosis: time-dependent receiver operating characteristics and decision curve analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  87. TOSON EA, Shiha GE, El-Mezayen HA, Samir W, et al
    Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients: angiogenic fibrogenic link.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  88. VOULGARIS T, Vlachogiannakos J, Ioannidou P, Papageorgiou MV, et al
    Adherence to follow-up and treatment recommendations in Greek and immigrant patients with chronic hepatitis B in Greece.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  89. ORDIERES C, Navascues CA, Gonzalez-Dieguez ML, Rodriguez M, et al
    Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  90. SELLIER PO, Maylin S, Bercot B, Chopin D, et al
    Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  91. SILVA MJ, Valente J, Capela T, Russo P, et al
    Epidemiology of hepatitis B in Portugal.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  92. LAPI F, Capogrosso Sansone A, Mantarro S, Simonetti M, et al
    Hepatitis C virus infection: opportunities for an earlier detection in primary care.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  93. WALLACE SJ, Webb GW, Madden RG, Dalton HC, et al
    Investigation of liver dysfunction: who should we test for hepatitis E?
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  94. MCEWAN P, Selvapatt N, Brown A, Thursz M, et al
    A clinician's guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspective.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  95. TURNER BJ, Liang Y, Singal A
    FIB-4 and imaging for measuring fibrosis in hepatitis C virus.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  96. NORDSTROM EM, Keniston A, Baouchi F, Martinez-Camacho A, et al
    Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  97. LI X, Gao F, Liu H, Zhang H, et al
    Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  98. WIJARNPREECHA K, Thongprayoon C, Ungprasert P
    Impact of caffeine in hepatitis C virus infection: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  99. WIJARNPREECHA K, Thongprayoon C, Panjawatanan P, Manatsathit W, et al
    Hepatitis B virus infection and risk of gallstones: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  100. ARDESIA M, Costantino G, Fries W
    Lower response to the hepatitis B vaccine in future inflammatory bowel disease patients.
    Eur J Gastroenterol Hepatol. 2016;28:1101-2.
    PubMed     Text format    


  101. BURLONE ME, Pedrinelli AR, Giarda P, Minisini R, et al
    Influence of age on sex-related differences among patients with hepatitis C.
    Eur J Gastroenterol Hepatol. 2016;28:1100-1.
    PubMed     Text format    


    August 2016
  102. SCHULZ M, Beha D, Plehm K, Zollner C, et al
    High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  103. LEWIS H, Kunkel J, Axten D, Dalton J, et al
    Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  104. BERT F, Rindermann A, Abdelfattah MA, Stahmeyer JT, et al
    High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  105. PARK CH, Kim HY, Lee SW, Song DS, et al
    On-treatment and off-treatment efficacy of entecavir in a real-life cohort of chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  106. MANCEBO M, Real LM, Mira JA, Recio E, et al
    Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  107. DYSON JK, Jopson L, Ng S, Lowery M, et al
    Improving testing for hepatitis B before treatment with rituximab.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  108. WANG P, Huang G, Tam N, Wu C, et al
    Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  109. PIERUCKA M, Stalke P, Zagozdzon P, Smiatacz T, et al
    The prevalence and co-occurrence of hematological complications at the time of diagnosis of chronic hepatitis C in Poland: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  110. MARCELLIN F, Fournier I, Carrieri MP, Poizot-Martin I, et al
    From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).
    Eur J Gastroenterol Hepatol. 2016;28:733-4.
    PubMed     Text format    


    May 2016
  111. KARAKOYUN M, Ecevit CO, Kilicoglu E, Aydogdu S, et al
    Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  112. MARCELLIN F, Protopopescu C, Poizot-Martin I, Miailhes P, et al
    Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  113. WANG H, Xu H, Qu L, Wang X, et al
    Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  114. TOSON EA, Shiha GE, El-Mezayen HA, El-Sharkawy AM, et al
    Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  115. YILMAZ B, Unlu O, Evcen R, Ugurluoglu C, et al
    Acute onset seronegative autoimmune hepatitis: are simplified diagnostic criteria sufficient?
    Eur J Gastroenterol Hepatol. 2016;28:607-8.
    PubMed     Text format    


  116. ABDEL-RAZIK A, Elhelaly R, Elzehery R, El-Diasty A, et al
    Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
    Eur J Gastroenterol Hepatol. 2016;28:599-605.
    PubMed     Text format     Abstract available


    April 2016
  117. ZEUZEM S, Mantry P, Soriano V, Buynak RJ, et al
    Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  118. KARAGOZ E, Tanoglu A, Ulcay A, Erdem H, et al
    Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  119. LISON H, Garioud A, Halfon P, Jambon S, et al
    Cytolytic hepatitis related to simeprevir overdose in a patient with cirrhosis and HIV-HCV genotype 1 coinfection.
    Eur J Gastroenterol Hepatol. 2016;28:486-7.
    PubMed     Text format    


    March 2016
  120. GULATI R, Nawaz M, Pyrsopoulos NT
    Comparative analysis of online patient education material pertaining to hepatitis and its complications.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  121. BOTTERO J, Boyd A, Gozlan J, Carrat F, et al
    Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  122. DINTSIOS CM
    Re: Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter? (Eur J Gastroenterol Hepatol 2015, 27:1063-1068).
    Eur J Gastroenterol Hepatol. 2016;28:362.
    PubMed     Text format    


  123. OZARAS R, Tahan V, Tabak F
    More on autoimmune hepatitis and acute hepatitis A.
    Eur J Gastroenterol Hepatol. 2016;28:360.
    PubMed     Text format    


    February 2016
  124. WASZCZUK E, Waszczuk KM, Mulak A, Paradowski L, et al
    Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  125. HELAL GK, Gad MA, Abd-Ellah MF, Mahgoup EM, et al
    Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  126. CARVALHANA SC, Leitao J, Alves AC, Bourbon M, et al
    Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  127. CORSI DJ, Karges W, Thavorn K, Crawley AM, et al
    Influence of female sex on hepatitis C virus infection progression and treatment outcomes.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  128. NIEDERAU C, Amani A, Thiel A
    Long-term follow-up of HBsAg-positive patients in Germany.
    Eur J Gastroenterol Hepatol. 2016;28:48-56.
    PubMed     Text format     Abstract available


    December 2015
  129. HUNTER JG, Madden RG, Stone AM, Osborne N, et al
    Locally acquired hepatitis E in Cornwall, the UK; geographical clustering, environmental and social factors: a case-controlled study coastal clustering of HEV; Cornwall, UK.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  130. SELLIER PO, Schnepf N, Amarsy R, Maylin S, et al
    Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  131. OZDEN HT
    Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  132. WANG H, Innes H, Hutchinson SJ, Goldberg DJ, et al
    The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  133. AIZAWA Y, Abe H, Sugita T, Seki N, et al
    Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  134. CHENG XP, Zhao J, Chen Y, Meng FK, et al
    Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  135. SAEZ-ROYUELA F, Linares P, Cervera LA, Almohalla C, et al
    Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  136. ABDEL-RAZIK A, Mousa N, Abdel-Aziz M, Elhelaly R, et al
    Elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  137. LAW ST, Lee MK, Li KK, Mok CK, et al
    Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  138. DETERDING K, Gruner N, Buggisch P, Galle PR, et al
    Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  139. MARTIN DJ, Weideman R, Crook T, Brown G, et al
    Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  140. ABDELFATTAH MR, Elsiesy H
    Reappraisal of upper age limit for adult living-donor liver transplantation using right lobe grafts: an outcome analysis.
    Eur J Gastroenterol Hepatol. 2015;27:593-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: